State Ledger
Company profile

Armata Pharmaceuticals, Inc. CIK 921114

Ticker
ARMP (NYSE)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Los Angeles, CA 90066
Fiscal year end
2025 (FY)
Market Data
Close
$3.08
Change
-$0.55
Change %
-15.15%
Volume
5,859

ARMP · trading date Oct 13, 2026 · previous close $3.63 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$173.80M
Total assets
$76.88M
Total liabilities
$295.48M
Stockholders' equity
-$218.60M
Cash & equivalents
$8.69M
Operating income
-$36.63M
Operating cash flow
-$25.76M
Capital expenditures
$542.0K

Fiscal year 2025, via 10-K filed 2026-03-25. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$26.31M
Free cash flow margin
—
Liabilities / assets
384.3%
Equity / assets
-284.3%
CapEx / revenue
—
Operating cash flow / net income
0.15×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$173.80M $76.88M $295.48M -$218.60M
2024 — -$18.92M $86.44M $134.46M -$48.02M
2023 — -$69.05M $98.36M $130.43M -$32.07M
2022 — -$36.92M $95.83M $59.75M $36.08M
2021 — -$23.16M $69.77M $44.37M $25.40M
Company Details
SIC code
2836
State of incorporation
WA
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-14
Financials filed via
Form 10-K
filed 2026-03-25

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Los Angeles, CA 90066
5005 MCCONNELL AVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:14 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies